Personalizing Health
search
Home
Corporate
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & Notice
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Announcements
Genetic Technologies Executes Settlement and License Agreement with AutoImmun Diagnostika GmbH
01 December 2011
Read more...
US Annual Report on Form 20-F
21 November 2011
US Annual Report on Form 20-F
Results from 2011 Annual General Meeting
21 November 2011
Results from 2011 Annual General Meeting
2011 Annual General Meeting materials
21 November 2011
2011 Annual General Meeting materials
ImmunAid Press Release
01 November 2011
ImmunAid Press Release
Previous Announcements
Forfeiture of options - 24 October 2011
Presentation at AusBiotech 2011
Genetic Technologies' BREVAGen changing the way US physicians assess breast cancer risk
2011 Notice of Annual General Meeting and Proxy
Appointment of Dr. Mervyn Cass
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 2 of 27
Announcements
Passing of Dr. Malcolm Simons
ASX Quarterly Reports - 31 December 2011
ASX share price query and response - 27 January 2012
Latest News
Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman
GTG Appoints Biotech Doyen Chairman
Ladenburg Thalmann Initiates Research Coverage.
Share Price